Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · IEX Real-Time Price · USD
1.490
+0.070 (4.93%)
At close: Mar 27, 2024, 4:00 PM
1.480
-0.010 (-0.67%)
After-hours: Mar 27, 2024, 7:24 PM EDT

Rigel Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1997
Revenue
116.88120.24149.24108.6259.2944.514.4820.3828.98.25
Upgrade
Revenue Growth (YoY)
-2.79%-19.43%37.39%83.21%33.20%892.62%-78.00%-29.46%250.24%15.38%
Upgrade
Cost of Revenue
7.111.751.080.90.910.290000
Upgrade
Gross Profit
109.77118.49148.15107.7358.3844.224.4820.3828.98.25
Upgrade
Selling, General & Admin
105.74112.4591.8976.674.597037.8320.9117.8122.5
Upgrade
Research & Development
24.5260.2765.2460.152.8946.946.2763.4562.8367.7
Upgrade
Other Operating Expenses
01.323.52000-0.735.68-0.069.2
Upgrade
Operating Expenses
130.26174.04160.65136.7127.47116.9183.3790.0480.5899.4
Upgrade
Operating Income
-20.49-55.55-12.5-28.97-69.09-72.68-78.88-69.65-51.69-91.15
Upgrade
Interest Expense / Income
6.873.714.861.350.3400000
Upgrade
Other Expense / Income
-2.27-0.68-0.05-0.58-2.53-2.2-0.89-0.44-0.22-0.24
Upgrade
Pretax Income
-25.09-58.57-17.31-29.74-66.89-70.48-77.99-69.22-51.46-90.91
Upgrade
Income Tax
000.610000000
Upgrade
Net Income
-25.09-58.57-17.91-29.74-66.89-70.48-77.99-69.22-51.46-90.91
Upgrade
Shares Outstanding (Basic)
174172170169167161126948888
Upgrade
Shares Outstanding (Diluted)
174172170169167161126948888
Upgrade
Shares Change
0.93%1.12%1.03%0.81%4.28%27.08%33.84%6.73%0.88%0.43%
Upgrade
EPS (Basic)
-0.14-0.34-0.11-0.18-0.40-0.44-0.62-0.73-0.58-1.04
Upgrade
EPS (Diluted)
-0.14-0.34-0.11-0.18-0.40-0.44-0.62-0.73-0.58-1.04
Upgrade
Free Cash Flow
-5.48-73.325.25-53.45-42.97-59.93-76.99-76.61-23.9-69.93
Upgrade
Free Cash Flow Per Share
-0.03-0.420.03-0.32-0.26-0.37-0.61-0.81-0.27-0.80
Upgrade
Gross Margin
93.92%98.55%99.27%99.18%98.47%99.36%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-17.53%-46.20%-8.37%-26.67%-116.53%-163.30%-1759.23%-341.72%-178.88%-1104.86%
Upgrade
Profit Margin
-21.47%-48.71%-12.00%-27.38%-112.83%-158.35%-1739.34%-339.58%-178.11%-1101.92%
Upgrade
Free Cash Flow Margin
-4.69%-60.97%3.52%-49.21%-72.47%-134.65%-1716.97%-375.83%-82.71%-847.66%
Upgrade
EBITDA
-16.98-53.87-11.29-27.69-65.88-69.89-77.53-68.28-50.03-88.55
Upgrade
EBITDA Margin
-14.53%-44.80%-7.56%-25.49%-111.11%-157.02%-1728.97%-334.96%-173.13%-1073.32%
Upgrade
Depreciation & Amortization
1.2411.160.710.680.590.470.941.442.36
Upgrade
EBIT
-18.22-54.87-12.45-28.39-66.56-70.48-77.99-69.22-51.46-90.91
Upgrade
EBIT Margin
-15.59%-45.63%-8.34%-26.14%-112.26%-158.35%-1739.34%-339.58%-178.11%-1101.92%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).